Spinal and cerebral tumefactive MS, clinical and neuroimaging Correlations



intramedullary spinal tumor, MRI, primary CNS lymphoma, tumefactive MS


The detection of tumefactive multiple sclerosis (TMS) often leads to diagnostic uncertainty, especially if lesions occur in patients without currently known demyelinating disease.
Supratentorial TMS can be differentiated from tumor by some specific imaging features: discrepancy between lesion size and mass effect; specific contrast pattern - open ring directed toward gray matter.
A major challenge is differentiating TMS from primary CNS lymphoma (PCNSL). Suspicion of a brain tumor often necessitates biopsy, which may also show misleading patho-histologic findings.
In the setting of a solitary tumor-like lesion in the myelon, diagnostic efforts are directed at excluding spinal intramedullary tumors.
Two clinical cases suggestive of tumor-like MS in the brain and spinal cord are presented with discussion and suggestions for diagnostic approaches to refine the diagnosis. Tumefactive MS is an uncommon and difficult-to-diagnose form of primary demyelination, making integration of clinical and laboratory data with imaging results and infrequent case follow-up over time extremely important.


Thompson, A., Banwell, B., Barkhof, F., Carroll, W., Coetzee, T., Comi, G. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb; 17, 2, 162-173.

Algahtani, H., Shirah, B., Alassiri, A. Tumefactive demyelinating lesions: A comprehensive review. Mult Scler Relat Disord, 2017 May, 14, 72-79.

Kuroda, Y., Kawasaki, T., Haraoka, S., Fujiyama, F., Kakigi, R., Abe. Et al. Autopsy report of primary CNS B-cell lymphoma indistinguishable from multiple sclerosis: diagnosis with the immunoglobulin gene rearrangements analysis. J Neurol Sci. 1992 Sep, 111, 2, 173-179.

Ng, S., Butzkueven, H., Kalnins, R., Rowe, C. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. J Clin Neurosci. 2007 Nov, 14, 11, 1126-1129.

Vaquero J, Martinez R, Ross E, et al. Primary cerebral lymphoma: the „ghost tumor” Case report. J Neurosurg 60, 174-176, 1984.

Alderson L, Fetell MR, Sisti M, Hochberg F, Cohen M, Louis DN. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry. 1996 Jan, 60, 1, 102-105.

Makary, M., Kirsch, C. Tumefactive demyelinating disease with isolated spinal cord involvement. Acta Radiol Short Rep. 2014 Jun 20, 3, 5.

White, J., Miller, G., Layton, K., Krauss, W. Nonenhancing tumors of the spinal cord. J Neurosurg Spine. 2007 Oct, 7, 4, 403-407.

Ropper, A., Samuels, M., Klein, J., Prasad, S. Diseases of the Spinal Cord In: Adams and Victor’s Principles of Neurology – 11th ed., McGraw-Hill, Inc., 2019, 1297.



How to Cite

Topalov, N., Ivanova, S., Bogdanova, D., Todorov, V., & Kalaidjiev, N. (2023). Spinal and cerebral tumefactive MS, clinical and neuroimaging Correlations. Bulgarian Neurology, 24(3), 116–118. Retrieved from https://www.nevrologiabg.com/journal/index.php/neurology/article/view/150